Valeant’s Deal for Salix Continues Frenzied Deal-Making in Drug Sector by ROBERT CYRAN

By ROBERT CYRAN

There is relief among Valeant’s backers that the company has returned to signing deals, after its long chase of Allergan left it empty-handed.

Published: February 24, 2015 at 12:00AM

from NYT Business Day http://ift.tt/1FPxmIu

from WordPress http://ift.tt/1D4iiAF

via Hadi Aboukhater